PDL BioPharma Inc (NASDAQ:PDLI)

2.48
Delayed Data
As of Feb 23
 -0.02 / -0.80%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.49%
Year-to-Date
No recent news for PDL BioPharma Inc.

Today’s Trading

Previous close2.50
Today’s open2.51
Day’s range2.46 - 2.56
Volume869,496
Average volume (3 months)1,501,596
Market cap$382.8M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)+55.13%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio5.0
Price/Sales1.45
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.10+2.11%
ATRAAtara Biotherapeutic...+1.10+2.56%
CYADCelyad SA-0.98-2.38%
BCRXBioCryst Pharmaceuti...+0.22+4.58%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)$0.11
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts